RELIEF THERAPEUTICS Holding Ltd.
RLF
ISIN CH1251125998 / Valor 125112599
RELIEF THERAPEUTICS Holding Ltd.
UMushroom community rating:
About company
Relief Therapeutics Holding Ltd. is a Swiss clinical-stage biopharmaceutical company that develops and seeks to commercialize therapies for acute and life‑threatening conditions, with a strategy that emphasizes advancing clinical-stage candidates (including repurposed molecules) through regulatory review and partnering or licensing for commercialization. The company operates with a pipeline focused on severe respiratory and other critical indications, pursues collaboration and licensing deals to fund development and broaden market access, and — as is typical for small-cap biotech firms — generates little or no product revenue while bearing the development and regulatory risks associated with clinical trials and approval processes.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
6 M
Market cap (USD)
526,519
Daily traded volume (Shares)
4.59 / 4.26
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
